These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Is there any drug treatment of choice for the borderline patient? Soloff PH Acta Psychiatr Scand Suppl; 1994; 379():50-5. PubMed ID: 8010152 [TBL] [Abstract][Full Text] [Related]
7. Does aripiprazole protect from serotonin syndrome? Rittmannsberger H; Werl R Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095 [No Abstract] [Full Text] [Related]
8. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. Hollander E J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814 [TBL] [Abstract][Full Text] [Related]
9. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article. Rosenberg R Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036 [TBL] [Abstract][Full Text] [Related]
10. Venlafaxine in the treatment of borderline personality disorder. Markovitz PJ; Wagner SC Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for social anxiety disorder: an update. Van Ameringen M; Mancini C; Patterson B; Simpson W Isr J Psychiatry Relat Sci; 2009; 46(1):53-61. PubMed ID: 19728573 [TBL] [Abstract][Full Text] [Related]
12. Depression in children and adolescents. Hazell P Am Fam Physician; 2003 Feb; 67(3):577-9. PubMed ID: 12588080 [No Abstract] [Full Text] [Related]
13. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? Abraham PF; Calabrese JR J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647 [TBL] [Abstract][Full Text] [Related]
14. [Applications and safety of modern antidepressants in patients with liver diseases]. Dubarek W; Kucia K Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of antidepressants. Artigas F; Nutt DJ; Shelton R Psychopharmacol Bull; 2002; 36 Suppl 2():123-32. PubMed ID: 12490828 [TBL] [Abstract][Full Text] [Related]
17. Drug treatment of the personality disorders. Stein G Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689 [TBL] [Abstract][Full Text] [Related]
18. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [TBL] [Abstract][Full Text] [Related]
19. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials. Einarson TR; Arikian SR; Casciano J; Doyle JJ Clin Ther; 1999 Feb; 21(2):296-308. PubMed ID: 10211533 [TBL] [Abstract][Full Text] [Related]
20. Depression in children and adolescents. Hazell P Clin Evid; 2004 Jun; (11):391-402. PubMed ID: 15652011 [No Abstract] [Full Text] [Related] [Next] [New Search]